NEW YORK (GenomeWeb) – OncoDNA said today that it signed a distribution agreement with Providens to market and distribute its cancer genomic tests to oncologists and their patients in Croatia, Bosnia-Herzegovina, Slovenia, Serbia, Montenegro, and Macedonia.

Providens will give physicians in the region access to OncoDNA's molecular profiling technology, which combines analysis of liquid and solid biopsies for patients with metastatic cancer, the company said.